Cardiac amyloid presenting as cardiogenic shock: case series
Related Experiment Video
Updated: Oct 25, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Monique Oye1, Pooja Dhruva1, Fadi Kandah1
1Department of Internal Medicine, Internal Medicine Resident, UF Health Jacksonville, 655, W 8th street, Jacksonville, FL 32209-6595, USA.
Insights
Cardiac amyloidosis, a serious infiltrative disease, can present as cardiogenic shock, particularly in African-American patients. Early diagnosis is crucial for better outcomes, as delayed detection often leads to fatal results despite aggressive treatment.
Area of Science:
- Cardiology
- Nephrology
- Hematology
Background:
- Amyloidosis is a systemic disease caused by misfolded protein deposition.
- Cardiac involvement significantly worsens prognosis in amyloidosis patients.
Observation:
- Two African-American patients presented with cardiac amyloidosis leading to cardiogenic shock.
- Missed diagnostic opportunities occurred prior to their critical presentations.
- One patient had light-chain amyloidosis with preserved ejection fraction; the other had transthyretin amyloidosis with reduced ejection fraction.
Findings:
- Cardiac amyloidosis can mimic common heart failure causes, especially in African-Americans.
- Presentation as cardiogenic shock indicates a poor prognosis, often rapidly fatal.
- Aggressive treatments were insufficient to prevent fatal outcomes in these cases.
Implications:
- Increased awareness and earlier diagnostic strategies for cardiac amyloidosis are vital.
- Timely diagnosis can potentially alter the typically fatal course of the disease.
- This case series highlights diagnostic challenges and the critical need for prompt recognition in at-risk populations.
Background:
Amyloidosis is a systemic infiltrative disease that can affect nearly every organ in the human body. It is characterized by the deposition of misfolded protein within various tissues and organs. Once there is cardiac involvement this portends a worse prognosis.
Case Summary:
We describe a case series of two patients with cardiac amyloidosis presenting as a cardiogenic shock. There were several missed opportunities in diagnosing cardiac amyloid prior to their fatal presentations. In the first case, a 65-year-old African-American male patient presented with worsening shortness of breath and signs of heart failure. Echocardiography revealed preserved ejection fraction. He was diagnosed with light chain subtype of cardiac amyloidosis, and rapidly deteriorated during his admission. Patient in the second case is a 75-year-old African-American female who presented with worsening heart failure and hypotension. Echocardiography revealed reduced ejection fraction. She was diagnosed with transthyretin cardiac amyloid. Her clinical status worsened during admission and she went into cardiogenic shock requiring multiple vasopressors.
Discussion:
This case series discusses two incidences of cardiac amyloidosis presenting as cardiogenic shock in African-American patients. This article postulates that cardiac amyloidosis may be misdiagnosed for more common causes of heart failure especially among this demographic group. Once patients with cardiac amyloid present with cardiogenic shock their clinical course is typically rapidly fatal despite aggressive measures. Earlier detection is imperative to prevent poor outcomes.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Introduction Cardiac Emergencies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations

